Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administration

Neuroscience Letters

Volumn 438, Issue 3, 2008, Pages 312-316

  Marek, Gerard J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT2A receptors; Antidepressant drugs; Excitatory postsynaptic currents; Fluoxetine; Prefrontal cortex; Pyramidal cells; Selective serotonin reuptake inhibitors

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; FLUOXETINE; SEROTONIN 2A RECEPTOR; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVATION; DRUG EFFICACY; DRUG SENSITIVITY; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; IMPULSIVENESS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; ANALYSIS OF VARIANCE; ANIMAL; BRAIN CORTEX; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; DRUG INTERACTION; ELECTROSTIMULATION; IN VITRO STUDY; METHODOLOGY; PATCH CLAMP; PHYSIOLOGY; RADIATION EXPOSURE; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FLUOXETINE; MALE; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 44349186059     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.04.068     Document Type: Article

References (50)

1. Aghajanian G.K., and Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36 (1997) 589-599
2. Baron B.M., Ogden A.-M., Siegel B.W., Stegeman J., Ursillo R.C., and Dudley M.W. Rapid down regulation of β-adrenoceptors by co-administration of desipramine and fluoxetine. Eur. J. Pharmacol. 154 (1988) 125-134
3. Blackshear M.A., and Sanders-Bush E. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J. Pharmacol. Exp. Ther. 221 (1982) 303-308
4. 2 receptors induced in rat frontal cortex by repeated imipramine and citalopram. Naunyn Schmiedebergs Arch. Pharmacol. 367 (2003) 444-450
5. Butler M.O., Morinobu S., and Duman R.S. Chronic electroconvulsive seizures increase the expression of serotonin2 receptor mRNA in rat frontal cortex. J. Neurochem. 61 (1993) 1270-1276
6. Calabrese J.R., et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry 146 (2005) 149-155
7. 2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology 29 (2004) 1637-1647
8. Chaput Y., de Montigny C., and Blier P. Effects of a selective 5-HT reputake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 333 (1986) 342-348
9. Conn P.J., and Sanders-Bush E. Regulation of serotonin-stimulated 'phosphoinositide hydrolysis: relation to the serotonin 5-HT2 binding site. J. Neurosci. 6 (1986) 3669-3675
10. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., and Heninger G.R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatry 47 (1990) 411-418
11. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Moreno F.A., Heninger G.R., and Charney D.S. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol. Psychiatry 46 (1999) 212-220
12. Du J., Gray N.A., Falke C.A., Chen W., Yuan P., Szabo S.T., Einat H., and Manji H. Modulation of synaptic plasticity by antimanic agents: The role of AMPA glutamate receptor subunit 1 synaptic expression. J. Neurosci. 24 (2004) 6578-6589
13. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
14. 2 sites. Life Sci. 32 (1983) 2677-2684
15. Fuxe K., Ogren S.-O., Agnati L., Benfenati F., Fredholm B., Andersson K., Zini I., and Eneroth P. Chronic antidepressant treatment and central 5-HT synapses. Neuropharmacology 22 (1983) 389-400
16. 2 and β-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J. Neurochem. 62 (1994) 2262-2268
17. 2 receptors in rat brain: an autoradiographic study. Synapse 14 (1993) 324-331
18. 2 receptors in the rat brain. J. Psychiatry Neurosci. 19 (1994) 63-67
19. 2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39 (2000) 471-481
20. Lambe E.K., and Aghajanian G.K. The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex. J. Neurosci. 21 (2001) 9955-9963
21. 11-proteins. Brain Res. 775 (1997) 225-228
22. Li X., Witkin J.M., Need A.B., and Skolnick P. Enhancement of antidepressant potency by a potentiator of AMPA receptors. Cell. Mol. Neurobiol. 23 (2003) 419-430
23. 1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur. J. Pharmacol. 367 (1999) 197-206
24. Marek G.J., and Seiden L.S. Antidepressant drug screens and the serotonin system. In: Palomo T., and Archer T. (Eds). Strategies for Studying Brain Disorders: Depressive, Anxiety and Drug Abuse Disorders (1994), Farrand Press, London 23-40
25. 2A and group II metabotropic glutamate receptors in prefrontal cortex. J. Pharmacol. Exp. Ther. 292 (2000) 76-87
26. Marek G.J., Wright R.A., Gewirtz J.C., and Schoepp D.D. A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience 105 (2001) 379-392
27. 2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28 (2003) 402-412
28. 2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology 30 (2005) 2205-2215
29. Marek, G.J., Regulation of rat cortical 5-hydroxytryptamine2A-receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine, Eur. Neuropsychopharmacol. (2008), doi:10.1016/j.euroneuro.2008.01.003.
30. Martin J.R., Bos M., Jenck F., Moreau J., Mutel V., Sleight A.J., Wichmann J., Andrews J.S., Berendsen H.H., Broekkamp C.L., Ruigt G.S., Kohler C., and Delft A.M. 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J. Pharmacol. Exp. Ther. 286 (1998) 913-924
31. Martinez-Turrillas R., Frechilla D., and Del Rio J. Chronic antidepressant treatment increases the membraine expression of AMPA receptors in rat hippocampus. Neuropharmacology 43 (2002) 1230-1237
32. McMahon F.J., Buervenich S., Charney D.S., Lipsky R., Rush A.J., Wilson A.F., Sorant A.J.M., Papanicolaou G.J., Laje G., Fava M., Trivedi M.H., Wisniewski S.R., and Manji H. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am. J. Hum. Genet. 78 (2006) 804-814
33. Murphy G.M.J., Kremer C., Rodriques H.E., and Schatzberg A.F. Pharmacogenetics of antidepressant medication intolerance. Am. J. Psychiatry 160 (2003) 1830-1835
34. Peroutka S.J., and Snyder S.H. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210 (1980) 88-90
35. Riblet L.A., and Taylor D.P. Pharmacology and neurochemistry of trazodone. J. Clin. Psychopharmacol. 1 (1981) 17S-22S
36. Richelson E. Pharmacology of antidepressants. Mayo Clin. Proc. 76 (2001) 511-527
37. Rueter L.A., De Montigny C., and Blier P. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems. J. Pharmacol. Exp. Ther. 285 (1998) 404-412
38. Sanders-Bush E., Breeding M., Knoth K., and Tsutsumi M. Sertraline-induced desensitization of the serotonin 5-HT-2 receptor transmembrane signalling system. Psychopharmacology 99 (1989) 64-69
39. 2A heteroceptors on thalamocortical glutamatergic neurons. J. Neurosci. 20 (2000) 8846-8852
40. 3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behavior. Psychopharmacology 80 (1983) 150-155
41. Todd K.G., McManus D.J., and Baker G.B. Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytrytpamine2A receptors without affecting benzodiazepine binding sites in rat brain. Cell. Mol. Neurobiol. 15 (1995) 361-370
42. Tohen M., Vieta E., Calabrese J., Ketter T.A., Sachs G., Bowden C., Mitchell P.B., Centorrino F., Risser R., Baker R.W., Evans A.R., Beymer K., Dube S., Tollefson G.D., and Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry 60 (2003) 1079-1088
43. Umbricht D., Vollenweider F.X., Schmid L., Grubel C., Skrabo A., Huber T., and Koller R. Implications for the neuropharmcology of cognitive deficits in schizophrenia. Neuropsychopharmacology 28 (2003) 170-181
44. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F.I., Babler A., Vogel H., and Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport 9 (1998) 3897-3902
45. Wamsley J.K., Byerly W.F., McCabe R.T., McConnell E.J., Dawson T.M., and Grosser B.I. Receptor alterations associated with serotonergic agents: an autoradiographic analysis. J. Clin. Psychiatry 48 Suppl. (1987) 19-25
46. Winstanley C.A., Chudasama Y., Dalley J.W., Theobald D.E.H., Glennon J.C., and Robbins T.W. Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology 167 (2003) 304-314
47. Winstanley C.A., Theobald D.E.H., Dalley J.W., Glennon J.C., and Robbins T.W. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology 176 (2004) 376-385
48. Yatham L.N., Liddle P.F., Dennie J., Shiah I.S., Adam M.J., Lane C.J., Lam R.W., and Ruth T.J. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch. Gen. Psychiatry 56 (1999) 705-711
49. 2A receptor-mediated prefrontal cortical excitatory synaptic currents and DOI-induced head shakes. Prog. Neuropsychopharmacol. Biol. Psychiatry 320 (2007) 437-447
50. Zhang Z.-W. Serotonin induces tonic firing in layer V pyramidal neurons of rat prefrontal cortex during postnatal development. J. Neurosci. 23 (2003) 3373-3384